RicercaInizia una nuova ricerca
NOTA: è possibile cercare una corrispondenza esatta usando i doppi apici, ad es: "evoluzione della specie". Qualora si cerchi un identificativo, è consigliabile cercarlo in due modi differenti: tra apici con caratteri speciali es: "978-94-6366-274" oppure senza caratteri speciali solo come sequenza numerica: es 978946366274.
Update on natural killer cells: cross-talk with dendritic cells and role in the cure of acute myeloid leukemias.
2003-01-01 Moretta, Alessandro; Ferlazzo, G; Mingari, MARIA CRISTINA; Melioli, G; Moretta, Lorenzo
Uptake of CCR7 and acquisition of migratory properties by human KIR+ NK cells interacting with monocyte-derived DC or EBV cell lines: regulation by KIR/HLA-class I interaction.
2009-01-01 Marcenaro, Emanuela; Cantoni, Claudia; Pesce, Silvia; Prato, C; Pende, D; Agaugué, S; Moretta, Alessandro; Moretta, Lorenzo
Use of anti-CD3 and anti-CD16 bispecific monoclonal antibodies for the targeting of T and NK cells against tumor cells.
1993-01-01 Ferrini, S; Cambiaggi, A; Sforzini, S; Canevari, S; Mezzanzanica, D; Colnaghi, Mi; Moretta, Lorenzo
What is a natural killer cell?
2002-01-01 Moretta, Alessandro; Bottino, Cristina; Mingari, MARIA CRISTINA; Biassoni, R.; Moretta, Lorenzo
X-linked lymphoproliferative disease. 2B4 molecules displaying inhibitory rather than activating function are responsible for the inability of natural killer cells to kill Epstein-Barr virus-infected cells.
2000-01-01 Moretta, Lorenzo; Bottino, Cristina; Falco, M; Augugliaro, R; Giliani, S; Franceschini, R; Ochs, Hd; Wolf, H; Bonnefoy, Jy; Biassoni, R; Moretta, L; Notarangelo, Ld; Moretta, Alessandro
XLP1 inhibitory effect by 2B4 does not affect DNAM-1 and NKG2D activating pathways in NK cells.
2014-01-01 Meazza, R; Tuberosa, C; Cetica, V; Falco, M; Loiacono, F; Moretta, Lorenzo; Micalizzi, C; Moretta, Alessandro; Mingari, MARIA CRISTINA; Moretta, L; Bottino, Cristina; Arico', M; Pende, D.
γδ T-cell reconstitution after HLA-haploidentical hematopoietic transplantation depleted of TCR-αβ+/CD19+ lymphocytes
2015-01-01 Airoldi, Irma; Bertaina, Alice; Prigione, Ignazia; Zorzoli, Alessia; Pagliara, Daria; Cocco, Claudia; Meazza, Raffaella; Loiacono, Fabrizio; Lucarelli, Barbarella; Bernardo, Maria Ester; Barbarito, Giulia; Pende, Daniela; Moretta, Alessandro; Pistoia, Vito; Moretta, Lorenzo; Locatelli, Franco
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Update on natural killer cells: cross-talk with dendritic cells and role in the cure of acute myeloid leukemias. | 1-gen-2003 | Moretta, Alessandro; Ferlazzo, G; Mingari, MARIA CRISTINA; Melioli, G; Moretta, Lorenzo | |
| Uptake of CCR7 and acquisition of migratory properties by human KIR+ NK cells interacting with monocyte-derived DC or EBV cell lines: regulation by KIR/HLA-class I interaction. | 1-gen-2009 | Marcenaro, Emanuela; Cantoni, Claudia; Pesce, Silvia; Prato, C; Pende, D; Agaugué, S; Moretta, Alessandro; Moretta, Lorenzo | |
| Use of anti-CD3 and anti-CD16 bispecific monoclonal antibodies for the targeting of T and NK cells against tumor cells. | 1-gen-1993 | Ferrini, S; Cambiaggi, A; Sforzini, S; Canevari, S; Mezzanzanica, D; Colnaghi, Mi; Moretta, Lorenzo | |
| What is a natural killer cell? | 1-gen-2002 | Moretta, Alessandro; Bottino, Cristina; Mingari, MARIA CRISTINA; Biassoni, R.; Moretta, Lorenzo | |
| X-linked lymphoproliferative disease. 2B4 molecules displaying inhibitory rather than activating function are responsible for the inability of natural killer cells to kill Epstein-Barr virus-infected cells. | 1-gen-2000 | Moretta, Lorenzo; Bottino, Cristina; Falco, M; Augugliaro, R; Giliani, S; Franceschini, R; Ochs, Hd; Wolf, H; Bonnefoy, Jy; Biassoni, R; Moretta, L; Notarangelo, Ld; Moretta, Alessandro | |
| XLP1 inhibitory effect by 2B4 does not affect DNAM-1 and NKG2D activating pathways in NK cells. | 1-gen-2014 | Meazza, R; Tuberosa, C; Cetica, V; Falco, M; Loiacono, F; Moretta, Lorenzo; Micalizzi, C; Moretta, Alessandro; Mingari, MARIA CRISTINA; Moretta, L; Bottino, Cristina; Arico', M; Pende, D. | |
| γδ T-cell reconstitution after HLA-haploidentical hematopoietic transplantation depleted of TCR-αβ+/CD19+ lymphocytes | 1-gen-2015 | Airoldi, Irma; Bertaina, Alice; Prigione, Ignazia; Zorzoli, Alessia; Pagliara, Daria; Cocco, Claudia; Meazza, Raffaella; Loiacono, Fabrizio; Lucarelli, Barbarella; Bernardo, Maria Ester; Barbarito, Giulia; Pende, Daniela; Moretta, Alessandro; Pistoia, Vito; Moretta, Lorenzo; Locatelli, Franco |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile
Opzioni
Scopri
Tipologia
- 01- Contributo su rivista 567
- 01- Contributo su rivista::01.01 ... 540
- 01- Contributo su rivista::01.05 ... 27
Data di pubblicazione
- In corso di stampa 2
- 2020 - 2024 7
- 2010 - 2019 129
- 2000 - 2009 182
- 1990 - 1999 115
- 1980 - 1989 112
- 1975 - 1979 20
Editore
- Wiley-VCH Verlag GmBH:PO Box 1011... 7
- American Society of Hematology 6
- Frontiers Media S.A. 6
- American Society of Hematology:19... 5
- Elsevier 5
- American Association of Immunolog... 4
- National Academy of Sciences:2101... 4
- Blackwell Munksgaard:PO Box 2148,... 3
- Elsevier Science Incorporated / N... 3
- Frontiers Research Foundation 3
Rivista
- EUROPEAN JOURNAL OF IMMUNOLOGY 102
- JOURNAL OF EXPERIMENTAL MEDICINE 44
- BLOOD 41
- JOURNAL OF IMMUNOLOGY 32
- PROCEEDINGS OF THE NATIONAL ACADE... 25
- INTERNATIONAL JOURNAL OF CANCER 17
- FRONTIERS IN IMMUNOLOGY 14
- INTERNATIONAL IMMUNOLOGY 14
Keyword
- Immunology 19
- Immunology and Allergy 16
- NK cells 16
- Humans 12
- Antigens 5
- Immunologic 5
- Killer Cells 5
- Natural 5
- Natural killer cells 5
- Oncology 5
Lingua
- eng 567
- ita 1
Accesso al fulltext
- no fulltext 514
- open 27
- reserved 25
- partially open 1